Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409344 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00409344: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00409344 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409344, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The primary objective of this study is to test the hypothesis that time on the ventilator and ICU length of stay will be shorter in TAA patients given postoperative sedation with dexmedetomidine compared to those given standard sedation. Secondary endpoints are: requirement for sedatives vasoactive drugs incidence of postoperative delirium and cost analysis.
Primary Outcome
Did not achieve this primary outcome due to no enrollment of participants. Unable to measure this outcome.
Interventions
- OTHER Normal Saline
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Why NCT00409344 stopped before completion
NCT00409344 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT00409344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00409344 about?
NCT00409344 is a clinical study titled "Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms". The primary objective of this study is to test the hypothesis that time on the ventilator and ICU length of stay will be shorter in TAA patients given postoperative sedation with dexmedetomidine compared to those given standard sedation. Secondary endpoints are: requirement for sedatives vasoactive ...
What is the current status of trial NCT00409344?
This trial is currently terminated. It is a Phase 4 study. The study started on 2007-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00409344?
The interventions under investigation include: Normal Saline (OTHER), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00409344?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia